Trials / Unknown
UnknownNCT05713201
Outcomes After PCI of the Aneurysmatic Right Coronary Artery
Percutaneous Coronary Interventions of the Aneurysmatic and Ectasic Right Coronary Artery in the Acute Setting: Management and Immediate- and Long-Term Outcomes The RIGHT-MARE Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 90 (estimated)
- Sponsor
- San Luigi Gonzaga Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This study aims to evaluate procedural and clinical outcomes of acute coronay syndrome (ACS) patients with aneurysmatic culprit right coronary artery (RCA).
Detailed description
The investigators sought differences in procedural (slow-flow, no-reflow, distal embolisation,Thrombolysis in Myocardial Infarction final flow (TIMI) etc.) and in immediate and long-term clinical outcomes between several subgroups such as index vs staged percutaneous coronary intervention (PCI), premedication vs none, use of IIb/IIIa inhibitors vs none, bare metal stent (BMS) vs drug eluting stent (DES), ultrathin DES vs thick DES, durable polymer vs bioresorbable or free polymer etc. The investigators also want to investigate the efficacy of different technical manoeuvres involved in resolving high thrombotic burden before stent deployment, such as thrombus aspiration, dilatation, intracoronary infusion of adenosine or thrombolytic agents, direct stenting etc.). Long-term follow-up includes target vessel failure (Cardiac Death, target vessel MI, clinically-driven target vessel revascularisation), define or probable stent thrombosis, target vessel revascularisation for ACS, clinically driven target vessel revascularisation and intrastent restenosis.
Conditions
- Coronary Disease
- Coronary Artery Ectasia
- Right Coronary Artery Occlusion
- Right Coronary Artery Stenosis
- STEMI
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Percutaneous Coronary Intervention | Treatment of coronary stenoses with a drug-eluting stent or balloon |
Timeline
- Start date
- 2022-11-01
- Primary completion
- 2024-04-01
- Completion
- 2024-12-01
- First posted
- 2023-02-06
- Last updated
- 2023-04-18
Locations
8 sites across 2 countries: Italy, Spain
Source: ClinicalTrials.gov record NCT05713201. Inclusion in this directory is not an endorsement.